SCHEMBL31729010

SCHEMBL31729010

Nc1nc(COCc2ccccc2)ns1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
ALOX15 P16050 1/20 0.47
ADORA3 P0DMS8 2/20 0.43
ADORA2A P29274 2/20 0.43
ADORA2B P29275 2/20 0.43
ADORA1 P30542 2/20 0.43
CYP3A4 P08684 1/20 0.41
KDM4E B2RXH2 1/20 0.40
POLB P06746 1/20 0.40
IDO1 P14902 1/20 0.38
AGXT P21549 1/20 0.37
GAA P10253 2/20 0.37
MGAM O43451 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
TAAR1 Q96RJ0 1/20 0.37
GHSR Q92847 2/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2358738 0.79 ALOX15 (0.53) RAB9ASMN1; SMN2ALOX15ADORA3ADORA2A
SCHEMBL29941235 0.76 TSHR (0.46) TSHRKDM4EPOLBL3MBTL1
SCHEMBL11318893 0.75 RAB9A (0.49) TSHRRAB9ASMN1; SMN2ALOX15ADORA3
Methane SCHEMBL11192510 0.73 TSHR (0.94) TSHRKDM4EPOLBIDO1AGXT
SCHEMBL26037955 0.71 TSHR (0.52) TSHRRAB9ASMN1; SMN2KDM4EIDO1
SCHEMBL27380 0.71 TSHR (1.00) TSHRKDM4EPOLBIDO1AGXT
SCHEMBL5311581 0.71 TSHR (1.00) TSHRKDM4EPOLBIDO1AGXT
Benzene SCHEMBL27997624 0.71 TSHR (1.00) TSHRKDM4EPOLBIDO1AGXT
SCHEMBL7427308 0.70 TSHR (0.50) TSHRRAB9ASMN1; SMN2ALOX15CYP3A4
SCHEMBL9670868 0.69 TSHR (0.75) TSHRRAB9ASMN1; SMN2ALOX15CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 WO disclosed